Shareholders' equity · 2015–2025
Arcus Biosciences shareholders' equity
$631M+30.1% · FY2025
Arcus Biosciences (RCUS) reported $631M in shareholders' equity for fiscal 2025, +30.1% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $631M | +30.1% | Open → |
| FY20242024-12-31 | $485M | +5.0% | Open → |
| FY20232023-12-31 | $462M | −29.7% | Open → |
| FY20222022-12-31 | $657M | −22.0% | Open → |
| FY20212021-12-31 | $842M | +67.7% | Open → |
| FY20202020-12-31 | $502M | +206.1% | Open → |
| FY20192019-12-31 | $164M | −30.2% | Open → |
| FY20182018-12-31 | $235M | +$307M | Open → |
| FY20172017-12-31 | −$72.3M | −$52.3M | Open → |
| FY20162016-12-31 | −$20.0M | −$17.8M | Open → |
| FY20152015-12-31 | −$2.2M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arcus Biosciences shareholders' equity |url=https://companiesranked.com/en/company/arcus-biosciences/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arcus Biosciences shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/arcus-biosciences/shareholders-equityBibTeX
@misc{companiesranked-en-company-arcus-biosciences-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Arcus Biosciences shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arcus-biosciences/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001724521-26-000044 · August 5, 2026
{{cite web |title=Arcus Biosciences shareholders' equity — 10-Q (0001724521-26-000044) |url=https://www.sec.gov/Archives/edgar/data/1724521/000172452126000044/rcus-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.